Yan D et al. Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies. Food Chem Toxicol. 1998 Dec;36(12):1095-106.
Yan D et al. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin. Toxicology. 1997 Sep 26;122(1-2):145-58.
Usui T et al. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. J Immunol. 1997 Apr 1;158(7):3197-204.
Bettina A, et al. M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes. J Immunol. 2016;196(12):5047-55.
Moor K et al. Peracetic Acid Treatment Generates Potent Inactivated Oral Vaccines from a Broad Range of Culturable Bacterial Species. Front Immunol. 2016;7:34.
Carrascal J et al. B-cell anergy induces a Th17 shift in a novel B lymphocyte transgenic NOD mouse model, the 116C-NOD mouse. Eur J Immunol. 2016;46(3):593-608.
Fleischhackerová A et al. Preparation and immunogenicity of conjugate based on hydrazine-treated lipopolysaccharide antigen of Vibrio cholerae O139. Biosci Biotechnol Biochem.
Kato T et al. Multiple omics uncovers host-gut microbial mutualism during prebiotic fructooligosaccharide supplementation. DNA Res. 2014;21(5):469-80.
Li J, et al. Intranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses. Hum Vaccin Immunother. 2014;10(5):1211-20.
Xu Q et al. Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children. Vaccine. 2014;32(6):706-11.
Price GA et al. Evaluation of TcpF-A2-CTB Chimera and Evidence of Additive Protective Efficacy of Immunizing with TcpF and CTB in the Suckling Mouse Model of Cholera. PLoS One.
Paulovičová L et al. Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate. Int Immunopharmacol. 2012;14(2):179-87.
Riewaldt J et al. Severe Developmental B Lymphopoietic Defects in Foxp3-Deficient Mice are Refractory to Adoptive Regulatory T Cell Therapy. Front Immunol.
Miao CH et al. Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice. Blood. 2006 Jul 1;108(1):19-27.
Jia Q et al. Docosahexaenoic acid and eicosapentaenoic acid, but not alpha-linolenic acid, suppress deoxynivalenol-induced experimental IgA nephropathy in mice. J Nutr. 2004 Jun;134(6):1353-61.
Mygind T et al. Identification of an in vivo CD4+ T cell-mediated response to polymorphic membrane proteins of Chlamydia pneumoniae during experimental infection. FEMS Immunol Med Microbiol. 2004 Mar 8;40(2):129-37.
Santiago-Raber ML et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med. 2003 Mar 17;197(6):777-88.
Schwartz RE et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002 May;109(10):1291-302.
Pestka JJ et al. Dietary fish oil suppresses experimental immunoglobulin a nephropathy in mice. J Nutr. 2002 Feb;132(2):261-9.
Pestka JJ et al. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion. Food Chem Toxicol. 2000 Jul;38(7):565-75.
Banotai C et al. Effects of vomitoxin ingestion on murine models for systemic lupus erythematosus. Food Chem Toxicol. 1999 May;37(5):533-43.
Banotai C et al. Effects of intermittent vomitoxin exposure on body weight, immunoglobulin levels and haematuria in the B6C3F1 mouse. Food Chem Toxicol. 1999 Apr;37(4):343-50.
Kieber-Emmons T et al. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nat Biotechnol. 1999 Jul;17(7):660-5.